findmyKOL

Xiaoduo Fan, MD

Enriched profile

Professor of Psychiatry and Behavioral Sciences, UMass Chan Medical School · University of Massachusetts Chan Medical School

ORCIDNPI
Region🇺🇸 Worcester, MA · Northeast · United StatesSpecialtyPsychiatryFocusSubstance Use Disorders+1
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2023Online presenceverified 2026Payments2023–2025NIH funding2008–2012

Xiaoduo Fan is Professor of Psychiatry and Behavioral Sciences, UMass Chan Medical School at University of Massachusetts Chan Medical School. OpenAlex indexes 134 publications with 4,538 citations (h-index 41); ClinicalTrials.gov lists 10 registered studies with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 1 Sept 2026

Xiaoduo Fan, MD, is Professor of Psychiatry and Behavioral Sciences, UMass Chan Medical School at University of Massachusetts Chan Medical School. The public record shows 134 publications with 4,538 citations (h-index 41), centered on Substance Use Disorders, Schizophrenia. It also documents an investigator role on 10 registered clinical trials, industry payments reported by 3 companies, 1 NIH-funded awards (2008–2012).

  • Most recent indexed publication: 2023 · Academic psychiatry
  • Top research focus: Substance Use Disorders
  • 10 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 3 companies

Generated from the cited public record · current as of 1 Sept 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Schizophrenia10 trialsPsychotic Disorders5 trialsSubstance Use Disorders1 trialSchizophrenia, Treatment-Resistant1 trial

Research focus

OpenAlex concept fingerprint
Substance Use DisordersSchizophrenia

Drugs & molecules

across trials, industry payments and publications
Rykindogeneric · RisperidoneClinical trialsIndustry payments10PublicationsRexultigeneric · BrexpiprazoleClinical trialsIndustry payments1Publications

Works with

trial sponsors and companies reporting payments
Luye Pharma (USA) Ltd.Clinical trialsIndustry payments10University of Massachusetts, WorcesterClinical trials8Industry paymentsE.R. Squibb & Sons, L.L.C.Clinical trialsIndustry payments5

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
134publications

Distinct works indexed by OpenAlex, matched via ORCID; 4 in PubMed.

4,538citations

Total citations across indexed works.

41h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
10clinical trials

Investigator role on registered studies.

View trials
3companies · 2023–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
1NIH grants · 2008–2012

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 1 Sept 2026

Listed as an investigator on 10 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 1 Sept 2026

3 companies reported payments to CMS in program years 2023–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    94.8%
    Atypical Antipsychotic42.5%
    Clozapine41%Olanzapine15%Risperidone15%Aripiprazole10%Lurasidone Hcl6%Quetiapine Fumarate5%Ziprasidone Hcl3%Invega Sustenna2%Rexulti2%Vraylar2%
    Part D<11 patients
    SSRI10.8%
    Trazodone Hcl36%Sertraline Hcl27%Fluoxetine Hcl16%Citalopram Hbr15%Paroxetine Hcl7%
    Part D<11 patients
  • Cardiovascular

    4.2%
    alpha-Adrenergic Blocker2.8%
    Prazosin Hcl100%
    Part D<11 patients
    Beta blocker1.4%
    Propranolol Hcl100%
    Part D<11 patients
  • Respiratory

    1%
    Anticholinergic1%
    Glycopyrrolate100%
    Part D<11 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 1 Sept 2026

1 NIH research award on record, funded 20082012 per NIH RePORTER. The latest:

Publications

Updated 1 Sept 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 1 Sept 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/xiaoduo-fan-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com

Mentions by others

where others cite or feature them
  • Facebook

    facebook.com/UMassMed/posts/greater-boston-interviewed-xiaoduo-fan-md-mph-regarding-a-new-study-on-racial-di/10156191503883361

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com
  • Instagram

    instagram.com/umassmind/p/C3bDQHytFOt

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com
  • Other

    apaf.org/library-archives/galleries/asian-american-trailblazers-in-psychiatry-past-present-future/xiaoduo-fan-m-d-m-p-h

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →apaf.org
1 more mention behind the reveal.Reveal →

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 1 Sept 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MD

    Peking Union Medical College

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →profiles.umassmed.edu
  • MPH

    Harvard University T.H. Chan School of Public Health

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →apaf.org
  • MS

    Clinical Psychology, University of Illinois at Chicago

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →profiles.umassmed.edu

Editorial & leadership roles

journal and society appointments
  • Director

    UMass MIND Clinical and Research Program

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →apaf.org
  • Director

    Psychotic Disorders Clinical and Research Program, UMass Chan Medical School

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →apaf.org
  • Director

    China Mental Health Program, UMass Chan Medical School

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →apaf.org
1 more role behind the reveal.Reveal →

Awards & honors

honors on the public record
2 more awards behind the reveal.Reveal →

Secondary affiliations

appointments beyond the home institution
  • Former staff psychiatrist

    Massachusetts General Hospital; former faculty, Harvard Medical School (~7 years, prior to UMass appointment)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →apaf.org

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.